Experimental antiviral pill taken at home is highly effective at preventing deaths, trial suggests
A large study of Pfizer’s experimental antiviral pill, paxlovid, has found that the drug can cut hospitalisations and deaths from Covid by nearly 90%, the company has said.
The US firm’s encouraging results, which are described in a press release but not yet peer-reviewed, suggest oral pills that can be taken at home are poised to take an increasing burden off hospitals that are still overstretched with Covid patients.
